These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 11500199)

  • 1. Familial defective apolipoprotein B-100: a mutation emerged in the Mesolithic period.
    Miserez AR; Muller PY
    Atherosclerosis; 2001 Sep; 158(1):253-4. PubMed ID: 11500199
    [No Abstract]   [Full Text] [Related]  

  • 2. Familial defective apolipoprotein B-100: a mutation emerged in the mesolithic ancestors of Celtic peoples?
    Miserez AR; Muller PY
    Atherosclerosis; 2000 Feb; 148(2):433-6. PubMed ID: 10657582
    [No Abstract]   [Full Text] [Related]  

  • 3. Incidence of the apolipoprotein B-3500 mutation in Denmark.
    Hansen PS; Nørgaard-Petersen B; Meinertz H; Jensen HK; Hansen AB; Klausen IC; Gerdes LU; Faergeman O
    Clin Chim Acta; 1994 Oct; 230(1):101-4. PubMed ID: 7850988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial defective apolipoprotein B-100 in hypercholesterolemic Chinese Canadians: identification of a unique haplotype of the apolipoprotein B-100 allele.
    Abdel-Wareth LO; Pimstone SN; Lagarde JP; Raisonnier A; Benlian P; Pritchard H; Hayden MR; Frohlich JJ
    Atherosclerosis; 1997 Dec; 135(2):181-5. PubMed ID: 9430367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial defective apolipoprotein B-100 in a group of hypercholesterolaemic patients in Poland. Identification of a new mutation Thr3492Ile in the apolipoprotein B gene.
    Bednarska-Makaruk M; Bisko M; Pulawska MF; Hoffman-Zacharska D; Rodo M; Roszczynko M; Solik-Tomassi A; Broda G; Polakowska M; Pytlak A; Wehr H
    Eur J Hum Genet; 2001 Nov; 9(11):836-42. PubMed ID: 11781700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial ligand-defective apolipoprotein B-100: simultaneous detection of the ARG3500-->GLN and ARG3531-->CYS mutations in a French population.
    Rabès JP; Varret M; Saint-Jore B; Erlich D; Jondeau G; Krempf M; Giraudet P; Junien C; Boileau C
    Hum Mutat; 1997; 10(2):160-3. PubMed ID: 9259199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Italian familial defective apolipoprotein B patients share a unique haplotype with other Caucasian patients.
    Cefalù AB; Barbagallo CM; Sesti E; Caldarella R; Polizzi F; Marino G; Noto D; Rolleri M; Travali S; Scalisi G; Notarbartolo A; Corsini A; Bertolini S; Averna MR
    Clin Exp Med; 2001 Sep; 1(3):151-4. PubMed ID: 11833852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid diagnosis of familial defective apolipoprotein B-100.
    Geisel J; Schleifenbaum T; Weisshaar B; Oette K
    Eur J Clin Chem Clin Biochem; 1991 Jun; 29(6):395-9. PubMed ID: 1912089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial hypercholesterolemia and familial defective apolipoprotein B-100: comparison of the phenotypic expression In 116 cases.
    Brugger D; Schuster H; Zöllner N
    Eur J Med Res; 1996 May; 1(8):383-6. PubMed ID: 9360938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of FDB3500 mutation in the Swiss population.
    Fisher E; Gross W; März W
    Atherosclerosis; 2000 Dec; 153(2):519-21. PubMed ID: 11187855
    [No Abstract]   [Full Text] [Related]  

  • 11. Familial defective apolipoprotein B-100.
    Hansen PS
    Dan Med Bull; 1998 Sep; 45(4):370-82. PubMed ID: 9777289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monogenic primary hypercholesterolaemia in South Africa.
    Rubinsztein DC; van der Westhuyzen DR; Coetzee GA
    S Afr Med J; 1994 Jun; 84(6):339-44. PubMed ID: 7740380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Familial apolipoprotein B-100 defect, a newly discovered lipid metabolism disorder].
    Ceska R
    Cas Lek Cesk; 1994 Nov; 133(22):686-9. PubMed ID: 7805094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial defective apolipoprotein B-100 is clinically indistinguishable from familial hypercholesterolemia.
    Defesche JC; Pricker KL; Hayden MR; van der Ende BE; Kastelein JJ
    Arch Intern Med; 1993 Oct; 153(20):2349-56. PubMed ID: 8215738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial defective apolipoprotein B-100: a study of patients from lipid clinics in Scotland and Wales.
    Wenham PR; Bloomfield P; Blundell G; Penney MD; Rae PW; Walker SW
    Ann Clin Biochem; 1996 Sep; 33 ( Pt 5)():443-50. PubMed ID: 8888978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial defective apolipoprotein B-100: a lesson from homozygous and heterozygous patients.
    Ceska R; Vrablík M; Horínek A
    Physiol Res; 2000; 49 Suppl 1():S125-30. PubMed ID: 10984082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic expression and frequency of familial defective apolipoprotein B-100 in Belgian hypercholesterolemics.
    Kotze MJ; Peeters AV; Langenhoven E; Wauters JG; Van Gaal LF
    Atherosclerosis; 1994 Dec; 111(2):217-25. PubMed ID: 7718024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to cholesterol-lowering drugs in familial defective apolipoprotein B-100.
    Maher VM; Gallagher JJ; Thompson GR; Myant NB
    Atherosclerosis; 1991 Nov; 91(1-2):73-6. PubMed ID: 1811555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of familial defective apolipoprotein B-100 in Finnish patients with elevated serum cholesterol.
    Hämäläinen T; Palotie A; Aalto-Setälä K; Kontula K; Tikkanen MJ
    Atherosclerosis; 1990 Jun; 82(3):177-83. PubMed ID: 2375782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetics of familial hypercholesterolemia.
    Chan L
    Beitr Infusionsther; 1988; 23():8-17. PubMed ID: 2484785
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.